Risk of Cervical Cancer Following Incident, Persistent and History-unknown HPV Detection
Risk of Cervical Cancer Following Incident, Persistent and History-unknown Human Papillomavirus (HPV) Detection by HPV Genotype
The goal of this register-based retrospective observational study is to understand the risk of cervical cancer following incident, persistent and history-unknown HPV detection by HPV genotype in healthy women participating in HPV-based cervical screening. The main questions it aims to answer are:
- Whether an incident HPV detection with certain HPV genotypes has low risk of cervical cancer in 3 to 5 years thus does not need further clinical assessment before the next screening test?
- How risky a persistent HPV detection is, and whether persistent detection of any high-risk HPV genotype warrant immediate clinical assessment?
- How risky a HPV detection is, if no previous HPV test result is available?
As being a register-based retrospective observational study, study subjects will not be asked to do any specific task for this study.
調査の概要
詳細な説明
This study includes all women in the study population (women at screening ages and living in the Stockholm region during 2014-2023) who had HPV positive test result(s) in the primary HPV screening. In 2014-2016, half of the screening population were randomised to primary HPV screening and the other half received cytology-based screening (NCT01511328). From 2017 onwards, all women received primary HPV screening. As data are retrieved from established registries which are already accessible to the researchers for previous and ongoing related research projects, the data collection time is almost negligible.
研究の種類
入学 (推定)
連絡先と場所
研究連絡先
- 名前:Jiangrong Wang, PhD
- 電話番号:+46769309451
- メール:jiangrong.wang@ki.se
研究連絡先のバックアップ
- 名前:Joakim Dillner, PhD
- メール:joakim.dillner@ki.se
研究場所
-
-
-
Stockholm、スウェーデン、141 52
- 募集
- Centre for Cervical Cancer Elimination, Department of Clinical Science, Intervention and Technology, Karolinska Institutet
-
コンタクト:
- Jiangrong Wang, PhD
- 電話番号:+46769309451
- メール:jiangrong.wang@ki.se
-
コンタクト:
-
副調査官:
- Jiangrong Wang, PhD
-
主任研究者:
- Joakim Dillner, PhD
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
サンプリング方法
調査対象母集団
Women living in the Great Stockholm Region in Sweden, at cervical screening ages (age 22-70 years), and having had an HPV positive result in the primary HPV test during 2014-2023
説明
Inclusion Criteria:
- Women living in the Great Stockholm Region in Sweden, at cervical screening ages (age 22-70 years), and having had an HPV positive result in primary HPV test during 2014-2023
Exclusion Criteria:
- Women without valid personal identity number in the population registry
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 観測モデル:COHORT
- 時間の展望:RETROSPECTIVE
コホートと介入
グループ/コホート |
介入・治療 |
|---|---|
|
Incident HPV detection
The first HPV positive result in the primary HPV test, following an HPV negative test result in the previous primary HPV test |
All data will be retrieved retrospectively from registry data. |
|
Persistent HPV detection
The HPV positive result in the primary HPV test following an HPV positive test result with the same genotype in the previous primary HPV test |
All data will be retrieved retrospectively from registry data. |
|
History-unknown HPV detection
The first HPV positive result in the primary HPV test, without any primary HPV test record in the past |
All data will be retrieved retrospectively from registry data. |
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Diagnosis of invasive cervical cancer
時間枠:From HPV infection to the end of the study Dec 31st, 2024
|
Primary and invasive cervical cancer |
From HPV infection to the end of the study Dec 31st, 2024
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Precancerous lesion CIN2+ (Cervical Intraepithelial Neoplasia grade 2 and above)
時間枠:From HPV infection to the end of the study Dec 31st, 2024
|
CIN2, CIN3, Adenocarcinoma in situ |
From HPV infection to the end of the study Dec 31st, 2024
|
協力者と研究者
スポンサー
出版物と役立つリンク
一般刊行物
- Bjorge T, Stoer NC, Hverven SK, Nygard M, Trope A, Engesaeter B. Risk of high-grade cervical lesions in the second round of primary human papillomavirus testing in CervicalScreen Norway: A population-based cohort study. Int J Cancer. 2025 Jul 15;157(2):251-259. doi: 10.1002/ijc.35359. Epub 2025 Feb 8.
- Wei F, Georges D, Man I, Baussano I, Clifford GM. Causal attribution of human papillomavirus genotypes to invasive cervical cancer worldwide: a systematic analysis of the global literature. Lancet. 2024 Aug 3;404(10451):435-444. doi: 10.1016/S0140-6736(24)01097-3.
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
追加の関連 MeSH 用語
その他の研究ID番号
- IPUHPV&CxCa
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
IPD will be derived from the Swedish National Cervical Screening Registry and the Swedish National Quality Register for Gynaecological Cancers. Data from these two registries can be shared upon application, provided that ethical approval is obtained.
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。